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In contrast to the current believe that angiotensin II (Ang II) only interacts with the sympathetic 
nervous system (SNS) as a circulating hormone, we document here the existence of an endogenous 
renin-angiotensin system (RAS) in the sympathetic coeliac ganglion and the angiotensinergic 
innervation with mesenteric resistant blood vessels. Our findings indicate that Ang II is synthesized 
inside the neurons of sympathetic coeliac ganglion and may act as an endogenous neurotransmitter 
locally on the mesenteric resistant blood vessels.
Blood pressure control is predominantly regulated by the SNS and the RAS. The octapeptide Ang II is the 
effector component of the RAS and well known as a potent inducer of vasoconstriction, which leads to 
increased blood pressure and release of aldosterone from the adrenal cortex. Hormonal Ang II circulating in 
the blood has been reported to interact with the SNS at different sites and to directly stimulate the 
sympathetic activity 1, 3, 6. Furthermore, it has been proposed that circulating Ang II functions at synaptic 
nerve endings e.g. with blood vessels by enhancing norepinephrine release and thereby facilitating 
sympathetic neurotransmission 1, 4, 5. The presence of RAS components in circulation and at tissue level has 
been reported 1, but the question of endogenous synthesis of Ang II in the SNS has not been addressed so far. 
Our study focused on the detection of different key components of RAS in sympathetic ganglions under 
normal physiological conditions. Thereby, we discovered the presence of an endogenous RAS in the 
normotensive rat sympathetic coeliac ganglion.
In order to demonstrate the synthesis of Ang II in the coeliac ganglion, we investigated the presence of key 
components of the RAS. Both, angiotensinogen (Ang-N) mRNA (Fig. 1a) and angiotensin converting 
enzyme (ACE) mRNA (Fig. 1c) was readily detected in total RNA extracts of rat coeliac ganglia by 
quantitative realtime RT-PCR (see Supplementary Methods online), whereas no renin mRNA could be 
traced (Fig. 1b). RNA from tissues with previously reported high levels of the respective mRNA was used as 
reference, and all mRNA values were normalised to 18S rRNA. At single cell resolution, Ang-N mRNA was 
detected in nearly all of the neurons in the rat coeliac ganglion by in situ hybridization (see Supplementary 
Methods online) with the antisense probe (Fig. 1d), but not with the sense probe used as a control (Fig.1e). 
Immunocytochemical studies using our previously characterized monoclonal antibody against Ang II 2
detected Ang II immunoreactivity in both the neuronal cytoplasm as well as in their projections in rat coeliac 
ganglia (Fig. 2a). In a transverse section of mesenteric resistance blood vessels, we can find strong 
angiotensinergic innervation (Fig. 2b). With confocal laser scanning microscopy (LSM), we were able to 
illustrate angiotensinergic synapses en passant (sympathetic varicosities) alongside the outer layer of 
vascular smooth muscle cells from rat (Fig. 2c-d). Likewise, we could also show the presence of Ang II in 
coeliac ganglia and mesenteric resistant blood vessels from human post mortem tissue (Fig. 3a-c).
Collectively, our results demonstrate expression of Ang-N and ACE mRNA in rat coeliac ganglia and the 
presence of Ang II in the cytoplasm of neurons of these coeliac ganglia, which suggests intracellular 
production of Ang II. Because we could not detect any renin expression in these neurons, the enzyme 
necessary for cleaving of Ang-N into the Ang I precursor of Ang II 1, we postulate that these neurons take up 
circulating renin to support synthesis of endogenous Ang II. This would be similar to cardiac tissue, where 
strong evidence exists for uptake of extracellular renin from the circulation 1, 7, 8, 9.
In conclusion, our findings strongly indicate the existence of an endogenous RAS in the sympathetic coeliac 
ganglion and a direct angiotensinergic innervation with mesenteric resistant blood vessels. Since the presence 
of Ang II type 1 receptors on vascular smooth muscle cells has been reported 1, our findings support the 
hypothesis that neuronally produced Ang II is released through synapses en passant and plays an important 
role in the regulation of blood pressure.
Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS
We are grateful to Berne University Research Foundation, Swiss Society of Hypertension and AstraZeneca for 
financial support. M.O. is a fellow of the Cloëtta Foundation. We are also thankful to Susanne Gygax and Tina 
Wettmann for technical assistance. 
1. Paul, M., Mehr, A.P. & Kreutz, R. Physiol. Rev. 86, 747-803 (2006). 
2. Frei, N. et al. Regul. Pept.101, 149-155 (2001).
3. Reid, I.A. Am. J. Physiol. 262, 763-778 (1992). 
4. Suter, C. & Coote, J.H. J. Auton. Nerv. Syst.19, 31-37 (1987).
5. Levens, N.R., Peach, M.J. & Carey, R.M. J. Clin. Invest. 67, 1197-1207 (1981).
6. Lewis, G.P. & Reit, E. J. Physiol.179, 538-553 (1965).
7. Danser, A.H. et al. Circulation 96, 220-226 (1997).
8. Schuijt, M.P. & Danser, A.H. Am J. Hypertens.15, 1109-1116 (2002).
9. Peters, J. et al. Circ. Res. 90, 1135-1141 (2002).
Figure 1 Determination of relative levels of angiotensinogen (Ang-N), renin and angiotensinogen converting 
enzyme (ACE) mRNA by quantitative realtime RT-PCR (RT-qPCR) and in situ hybridization of Ang-N 
mRNA in rat coeliac ganglia.
Reverse transcribed total RNA extracts of rat coeliac ganglia from different rats were tested by qPCR for the 
presence of Ang-N mRNA (a), for renin mRNA (b), and for ACE mRNA (c). Total RNA from liver (a), 
kidney (b), and lung (c) were used as a reference, respectively, and all relative mRNA values were 
normalized to 18S rRNA levels. Average values and standard deviations of 4 qPCR measurements are 
shown. For in situ hybridization, 6 m thick consecutive paraffin sections were processed as described in 
supplementary methods. d) antisense probe. e) control with sense probe, revealing no staining. Bar: 50 μm.
Figure 2 Ang II immunoreactivity with rat coeliac ganglion, mesenteric resistant blood vessels and the 
presence of angiotensinergic synapses en passant.
Cryosections of 30 μm thickness were incubated with our murine monoclonal anti Ang II antibody 2, stained 
with goat anti-mouse (GAMCy3) in red and DAPI in blue for nuclei (see Supplementary Methods online). a) 
Ang II staining in neurons and their projections of coeliac ganglion. Bar: 10 μm. b) Ang II staining with a 
mesenteric resistant blood vessel, transverse section. Bar: 50 μm. c) Ang II staining with mesenteric resistant 
blood vessels, longitudinal section. Bar: 50 μm. d) Zoomed inset of panel c. Visualization of angiotensinergic 
synapses en passant (indicated by arrows). Bar: 10 μm.
Figure 3 Ang II immunoreactivity with human coeliac ganglion, mesenteric resistant blood vessels and 
presence of angiotensinergic synapses en passant. 
Cryosections of 30 μm thickness were stained as in Fig. 2. a) Ang II staining in neurons and projections of 
coeliac ganglion. Bar: 50 μm. b) Ang II staining with mesenteric resistant blood vessels. Bar: 50 μm. c) 
Zoomed inset of panel b. Visualization of angiotensinergic synapses en passant (indicated by arrows). Bar: 
10 μm.
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Supplementary methods
Angiotensinergic innervation of rat and human mesenteric resistant blood vessels
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1. Tissue preparation
Wistar Kyoto (WKY) male rats were purchased (8-week-old, approximately 200 gram body weight) from the 
Central Animal Facilities of the University of Bern. According to the European Communities Council 
Directive of 24 November 1986 (86/609/EEC) and in accordance with Animal Protocols approved by the 
Animal Care and Use Committee, NIMH, NIH, USA, adequate measures were taken to minimize pain or 
discomfort. Rats were anaesthetized intraperitoneally with 100 mg/kg thiopentane sodium (Pentothal, Abbott 
Laboratories, Germany) and were perfused transcardially with 150 ml Ringer solution containing 1000 U 
heparin at 37 °C followed by 300 ml 2 % freshly prepared formaldehyde at 4 °C. Coeliac ganglia and 
mesenteric resistant blood vessels were carefully removed and incubated by immersion fixation in 2 % 
formaldehyde for 28 hours at 4 °C. Afterwards, coeliac ganglia and mesenteric blood vessels were immersed 
for 14 hours in phosphate-buffered saline containing 18 % sucrose at 4 °C. These tissues were frozen in 
isopentane at –50 °C and cryosections of 30 µm thicknesses were subsequently used free-floating for 
immunocytochemistry. After perfusion and immersion fixation, both rat tissues were also embedded in 
paraffin to perform additional experiments. 6 µm thick paraffin sections were used for immunocytochemical 
and for in situ hybridization. Human coeliac ganglia and mesenteric resistant blood vessels were procured 
from human individuals for whom a permit for clinical autopsy (informed written consent by next of kin) had 
been obtained according to state law, in accordance with the Code of Ethics of the World Medical 
Association (Declaration of Helsinki). Human coeliac ganglia were fixed by immersion in freshly prepared 
2% formaldehyde for 3 days and then used for cryosectioning or embedded in paraffin.
2. RNA isolation and quantitative realtime RT-PCR
Fresh rat coeliac ganglia were dissected as above and instantly transferred into RNA later (Ambion), frozen 
in liquid nitrogen, and then processed for the total RNA extraction (Ambion). RNA integrity was confirmed 
for each sample on the Agilent Bioanalyzer using the RNA 6000 Nano kit (Agilent Technologies). 1 g of 
total RNA was reverse transcribed using Supercript II (Invitrogen) and random hexamers according to the 
manufacturer’s protocol. For realtime PCR, reverse transcribed material corresponding to 40 ng RNA was 
amplified with the TaqMan assays described below in 25 l Universal PCR Master Mix, No AmpErase UNG 
on the SDS 7000 (Applied Biosystems) using the standard thermal protocol. Average values and standard 
deviations of relative mRNA levels of each sample, normalized to relative 18S rRNA levels, are from four 
measurements and were calculated using the relative differences.
The following TaqMan assays were used for realtime PCR at a final concentration of 250 nM TaqMan probe 
and 900 nM of each primer:
Angiotensinogen Forward primer 5’-CACGACTTCCTGACTTGGATAAAGA-3’; reverse primer 5’-
CTGCGGCAGGGTCAGA-3’; TaqMan probe 5’-FAM-CTCCTCGGGCCATCCG-MGB-3’; manufactured 
as Assays-by-Design (RATG-EJ3) by Applied Biosystems
Renin Assay-on-demand Rn00561847_m1 from Applied Biosystems
ACE Assay-on-demand Rn00561094_m1 from Applied Biosystems
18S rRNA: Predeveloped Assay Reagent 431-9413E from Applied Biosystems
3. In situ hybridization
3.1 DIG-labelled RNA probe preparation 
By using an appropriate Ang-N cDNA template 2, a 403 bp long fragment corresponding to nucleotides 221-
623 was generated by digestion with restriction enzymes EcoRV and BamHI. The obtained fragment was 
cloned between Stu I and Bam HI into pBluescript I KS+ (Stratagene). Digoxigenin-labelled probes were 
prepared using the DIG-RNA-labelling Mix (Roche, Basel, Switzerland) according to the manufacturer’s 
protocol. T7 RNA polymerase was used to generate antisense riboprobe using the HindIII linearized 
template, and the sense strand (used as a control) was generated by T3 RNA polymerase using the same 
template linearized with BamHI. The RNA concentration was estimated comparing dot-blot tests and 
NanoDrop measurements. Filter hybridization with RNA extracts from coeliac ganglia (RNaqueous-4PCR 
kit from Ambion) was used for binding tests.
3.2 In situ hybridization
For in situ hybridization, 6 µm thick paraffin sections were rehydrated in a graded alcohol series (2 times 
Xylol for 10 min, EtOH 100 % (2 times), 96 %, 70 %, 50 %, each step 5 min) using DEPC-treated H2O for 
the dilution of all reagents and solutions. The sections were equilibrated in proteinase K buffer (100 mM 
Tris, 50 mM EDTA, pH 7.5) for 5 minutes and then treated with proteinase K (19 µg/ml) at 37 ºC for 2 
minutes, after a wash with DEPC-treated H2O. Following a wash in DEPC-water, sections were post fixed 
with freshly prepared 4 % formaldehyde for 5 minutes, followed by two subsequent washes in DEPC-water 
for 5 minutes each. Sections were then incubated in prehybridization solution (SIGMA) at 45 °C for 2 hours, 
followed by incubation with heat denatured sense and antisense riboprobes (5-10 ng/µl) in 30 µl 
hybridization mix (SIGMA) for 48 hours at 45 °C in a humid chamber (saturated with 2x SSC). 
Subsequently, the sections were incubated with 2x SSC for 30 minutes at room temperature, followed by 
1hour in 2x SSC at 45 °C and 1 hour in 0.1x SSC at 45 °C. Sections were equilibrated for 5 minutes with 
buffer 1 (100 mM Tris, 150 mM NaCl, pH 7.5), then incubated with alkaline phosphatase-coupled anti-
digoxigenin antibody (Roche) 1:500 diluted in buffer 2 (10x blocking solution diluted with buffer 1) for 2 
hours at room temperature, followed by two 5 minutes washes with buffer 1. Finally, after 5 minutes 
equilibration with buffer 3 (100 mM Tris, 100 mM NaCl, 50 mM MgCl2, pH 9.5), the colour reaction 
containing NBT and BCIP in buffer 3 was completed according to manufacturer’s protocol (Sigma).
4. Immunocytochemistry
For immunocytochemical incubations, our protein G purified murine monoclonal antibody against Ang II 
was used at a concentration of 0.3 µg/ml in buffer solution. This is a self-generated affinity purified 
monoclonal antibody against the synthetic peptide Ang II (4B3). The specificity for this monoclonal antibody 
against Ang II (4B3) has been previously documented and it produced the same staining as polyclonal 
antibody against Ang II in rat adrenal glands 1. Pre-absorption was performed by incubation with Ang II 
peptide covalently linked through its N-terminus to CH-Sepharose 4 B. The gel was loaded into a glass 
column and the effluent was used for immunocytochemical controls. Incubations with this solution did not 
stain. Further controls, in which pre-immune mouse serum or the primary antibody has been omitted, also 
exhibited no staining. Goat anti-mouse immunoglobulins (GAMCy3; Jackson ImmunoResearch) pre-
incubated with rat serum prior to immunocytochemistry were used as secondary antibodies. Sections were 
incubated free floating for 36 hours at 4 ºC with the primary antibody, washed and incubated with the 
secondary antibody for 90 minutes at room temperature. After washing, cryosections were counterstained 
with DAPI, mounted on gelatine-coated slides and air-dried. The stained sections were embedded with 
Glycergel (DAKO) and cover-slipped. The same procedure as for free floating cryosections has been used for 
paraffin sections mounted on glass slides. Pictures were taken by a normal fluorescent light microscope 
(LEICA DM 6000B) using a digital camera or by a confocal laser scanning microscope (LEICA SP2 with 
AOBS).
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